Stine Nielsen
Biographic Data
| ID | 7446480 |
|---|---|
| NAME | Stine Nielsen |
| GIVEN NAMES | Stine |
| FAMILY NAME | Nielsen |
| SIGNATURE | NIELSEN S |
| AFFILIATIONS | Robert Koch Institute |
| ORCID | 0000-0002-5931-5379 |
| VERIFIED | Yes |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 7 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2007 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Developing and Piloting a Standardized European Protocol for Hepatitis C Prevalence Surveys in the General Population (2016–2019)
Background: A robust estimate of the number of people with chronic hepatitis C virus (HCV) infection is essential for an appropriate public health response and for monitoring progress toward the WHO goal of eliminating viral hepatitis. Existing HCV prevalence studies in the European Union (EU)/European Economic Area (EEA) countries are heterogeneous and often of poor quality due to non-probability based sampling methods, small sample sizes and la…
Risk behaviours and viral infections among drug injecting migrants from the former Soviet Union in Germany
STI tests and proportion of positive tests in female sex workers attending local public health departments in Germany in 2010/11
Participating LPHD varied in terms of performed STI tests and FSW visits. The proportion of positive STI tests was low, but varied between LPHD. This variation likely reflects different testing strategies. Existing testing guidelines should be used by all LPHD to ensure high quality care for FSW
High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs
In the recruited sample of mostly current injectors with a long duration of injecting drug use, seroprevalence for HIV and HCV varied greatly between the city samples. HCV was endemic among participants in all city samples. Our results demonstrate the necessity of intensified prevention strategies for blood-borne infections among PWID in Germany
A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling
We chose respondent driven sampling for recruitment of participants to improve representativeness of results. Persons, who are not reached by the facility where the study is conducted, are aimed to be included by recruitment through their personal social network of injecting drug users. To reduce differential biases in the questions on knowledge of transmission and prevention of infections, we present true statements on hepatitis B, C and HIV, th…
Access to highly active antiretroviral therapy (Haart) for women and children in the WHO European Region 2002–2006
Objective. To assess the level of access to highly active antiretroviral therapy (HAART) for women and children in the WHO European Region. Methods. Analysis of data from three national surveys of 53 WHO European Member States. The comparative level of access to HAART for women and children was assessed by comparing the percentage of reported HIV cases with the percentage of HAART recipients in women at the end of 2002 and 2006 and in children at…
Access to highly active antiretroviral therapy (Haart) for injecting drug users in the WHO European Region 2002–2004
No prominent works on this page.
Access to highly active antiretroviral therapy (Haart) for injecting drug users in the WHO European Region 2002–2004
Access to highly active antiretroviral therapy (Haart) for women and children in the WHO European Region 2002–2006
Objective. To assess the level of access to highly active antiretroviral therapy (HAART) for women and children in the WHO European Region. Methods. Analysis of data from three national surveys of 53 WHO European Member States. The comparative level of access to HAART for women and children was assessed by comparing the percentage of reported HIV cases with the percentage of HAART recipients in women at the end of 2002 and 2006 and in children at…
A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling
We chose respondent driven sampling for recruitment of participants to improve representativeness of results. Persons, who are not reached by the facility where the study is conducted, are aimed to be included by recruitment through their personal social network of injecting drug users. To reduce differential biases in the questions on knowledge of transmission and prevention of infections, we present true statements on hepatitis B, C and HIV, th…
STI tests and proportion of positive tests in female sex workers attending local public health departments in Germany in 2010/11
Participating LPHD varied in terms of performed STI tests and FSW visits. The proportion of positive STI tests was low, but varied between LPHD. This variation likely reflects different testing strategies. Existing testing guidelines should be used by all LPHD to ensure high quality care for FSW
High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs
In the recruited sample of mostly current injectors with a long duration of injecting drug use, seroprevalence for HIV and HCV varied greatly between the city samples. HCV was endemic among participants in all city samples. Our results demonstrate the necessity of intensified prevention strategies for blood-borne infections among PWID in Germany
Risk behaviours and viral infections among drug injecting migrants from the former Soviet Union in Germany
Developing and Piloting a Standardized European Protocol for Hepatitis C Prevalence Surveys in the General Population (2016–2019)
Background: A robust estimate of the number of people with chronic hepatitis C virus (HCV) infection is essential for an appropriate public health response and for monitoring progress toward the WHO goal of eliminating viral hepatitis. Existing HCV prevalence studies in the European Union (EU)/European Economic Area (EEA) countries are heterogeneous and often of poor quality due to non-probability based sampling methods, small sample sizes and la…
Medicine (7 works) · Family medicine (6 works) · HIV, Drug Use, Sexual Risk (6 works) · Environmental health (5 works) · HIV/AIDS Research and Interventions (5 works) · Demography (4 works) · Hepatitis C virus research (4 works) · Public health (4 works) · Biostatistics (3 works) · Demography (3 works)